AACR2020 myvac
B. Mallone et al.
AACR 2020
Download the poster here
Poster Presentation
Performance of neoantigen prediction for the design of TG4050, a patient specific neoantigen cancer vaccine
Par Lucie Larguier|2020-06-22T18:41:41+02:00juin 22nd, 2020|Myvac, Publication, TG4050|Commentaires fermés sur Performance of neoantigen prediction for the design of TG4050, a patient specific neoantigen cancer vaccine
À propos de l'auteur : Lucie Larguier
Articles similaires
- Design of an Innovative Model to Improve Anticancer Therapeutic Treatment Based on a Vascularized 3D Organoids Derived from Patients’ Lung Tumors for the Purpose of Precision Medicine
Design of an Innovative Model to Improve Anticancer Therapeutic Treatment Based on a Vascularized 3D Organoids Derived from Patients’ Lung Tumors for the Purpose of Precision Medicine
- BT-001, an oncolytic Vaccinia virus armed with a Treg-depletion-optimized recombinant human anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment
BT-001, an oncolytic Vaccinia virus armed with a Treg-depletion-optimized recombinant human anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment